Literature DB >> 11231553

Telomerized human microvasculature is functional in vivo.

J Yang1, U Nagavarapu, K Relloma, M D Sjaastad, W C Moss, A Passaniti, G S Herron.   

Abstract

Previously we showed the superior in vitro survival of human telomerase reverse transcriptase (hTERT)-transduced human endothelial cells (EC). Here we show that retroviral-mediated transduction of hTERT in human dermal microvascular EC (HDMEC) results in cell lines that form microvascular structures when subcutaneously implanted in severe combined immunodeficiency (SCID) mice. Anti-human type IV collagen basement membrane immunoreactivity and visualization of enhanced green fluorescent protein (eGFP)-labeled microvessels confirmed the human origin of these capillaries. No human vasculature was observed after implantation of HT1080 fibrosarcoma cells, 293 human embryonic kidney cells, or human skin fibroblasts. Intravascular red fluorescent microspheres injected into host circulation were found within green "telomerized" microvessels, indicating functional murine-human vessel anastamoses. Whereas primary HDMEC-derived vessel density decreased with time, telomerized HDMEC maintained durable vessels six weeks after xenografting. Modulation of implant vessel density by exposure to different angiogenic and angiostatic factors demonstrated the utility of this system for the study of human microvascular remodeling in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231553     DOI: 10.1038/85655

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  30 in total

1.  Quantifying signaling-induced reorientation of T cell receptors during immunological synapse formation.

Authors:  William C Moss; Darrell J Irvine; Mark M Davis; Matthew F Krummel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

2.  Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span.

Authors:  Riccardo E Nisato; Jillian A Harrison; Raphaele Buser; Lelio Orci; Chris Rinsch; Roberto Montesano; Philippe Dupraz; Michael S Pepper
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 3.  Smooth muscle and other cell sources for human blood vessel engineering.

Authors:  Sumati Sundaram; Laura E Niklason
Journal:  Cells Tissues Organs       Date:  2011-10-25       Impact factor: 2.481

Review 4.  Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.

Authors:  Karima Ait-Aissa; Johnathan D Ebben; Andrew O Kadlec; Andreas M Beyer
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

5.  Quantitative imaging of lymphocyte membrane protein reorganization and signaling.

Authors:  Peter M Kasson; Johannes B Huppa; Michelle Krogsgaard; Mark M Davis; Axel T Brunger
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

Review 6.  Effects of aging on angiogenesis.

Authors:  Johanna Lähteenvuo; Anthony Rosenzweig
Journal:  Circ Res       Date:  2012-04-27       Impact factor: 17.367

7.  Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells.

Authors:  Matthew J Frontini; Zengxuan Nong; Robert Gros; Maria Drangova; Caroline O'Neil; Mona N Rahman; Oula Akawi; Hao Yin; Christopher G Ellis; J Geoffrey Pickering
Journal:  Nat Biotechnol       Date:  2011-04-17       Impact factor: 54.908

8.  Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature.

Authors:  Xiaofang Chen; Anna S Aledia; Cyrus M Ghajar; Craig K Griffith; Andrew J Putnam; Christopher C W Hughes; Steven C George
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

Review 9.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

10.  Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.

Authors:  Taslim A Al-Hilal; Seung Woo Chung; Jeong Uk Choi; Farzana Alam; Jooho Park; Seong Who Kim; Sang Yoon Kim; Fakhrul Ahsan; In-San Kim; Youngro Byun
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.